Advertisement

Antibiotic Stewardship

  • Stephen D. Baird
Chapter

Abstract

Antibiotic stewardship is the establishment of a practice of reducing and eliminating the inappropriate usage of antibiotics. Antibiotics can be a lifesaving intervention when used appropriately. However, misuse must be guarded against to prevent a growing number of adverse effects. To implement a successful stewardship program, a multidisciplinary team must provide audit of prescribing patterns, give appropriate feedback, and identify both goals and barriers to success. When antibiotics are prescribed, they should be as narrow of spectrum and short of duration as possible while still maintaining their efficacy. Judicious use of antibiotics will limit antibiotic resistance and other adverse outcomes while optimizing infant outcomes.

Keywords

Antibiotic Antimicrobial stewardship Culture Infant Quality improvement 

References

  1. 1.
    Cotton CM, McDonald S, Stoll B, et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118:717–22.CrossRefGoogle Scholar
  2. 2.
    de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;355:973–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Cotton CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.CrossRefGoogle Scholar
  4. 4.
    Cantey JB, Huffman LW, Subramanian A, et al. Antibiotic exposure and risk for death or bronchopulmonary dysplasia in very low birth weight infants. J Pediatr. 2017;181:289–93.CrossRefPubMedGoogle Scholar
  5. 5.
    Ting JY, Synnes A, Roberts A, et al. Association of antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis. JAMA Pediatr. 2016;170:1181–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Sun W, Svendsen ER, Karmaus WJ, Kuehr J, Forster J. Early-life antibiotic use is associated with wheezing among children with high atopic risk: a prospective European study. J Asthma. 2015;52:647–52.CrossRefPubMedGoogle Scholar
  7. 7.
    Lapin B, Piorkowski J, Ownby D, et al. The relationship of early-life antibiotic use with asthma in at-risk children. J Allergy Clin Immunol. 2014;134:728–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Schmitt J, Schmitt NM, Kirch W, Meurer M. Early exposure to antibiotics and infections and the incidence of atopic eczema: a population-based cohort study. Pediatr Allergy Immunol. 2010;21:292–300.CrossRefPubMedGoogle Scholar
  9. 9.
    Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015;135:617–26.CrossRefPubMedGoogle Scholar
  10. 10.
    Korpela K, Zijlmans MA, Kuitunen M, et al. Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use. Microbiome. 2017;5:26.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.CrossRefPubMedGoogle Scholar
  12. 12.
    Cantey JB, Vora N, Sunkara M. Prevalence, characteristics, and perception of nursery antibiotic stewardship coverage in the United States. J Pediatric Infect Dis Soc. 2017;6:e30–5.PubMedGoogle Scholar
  13. 13.
    Patel S, Landers T, Larson E, et al. Clinical vignettes provide an understanding of antibiotic prescribing practices in neonatal intensive care units. Infect Control Hosp Epidemiol. 2011;32:597–602.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kimura T, Uda A, Sakaue T, et al. Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback. Infection. 2018;46(2):215–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Cantey JB, Wozniak PS, Pruszynski JE, Sanchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016;16:1178–84.CrossRefPubMedGoogle Scholar
  16. 16.
    Mehta JM, Haynes K, Wileyto EP, et al. Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol. 2014;35:1092–9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Chan S, Hossain J, DiPentima MC. Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital. Pediatr Infect Dis J. 2015;34:506–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Lukaszewicz Bushen J, Mehta JM, Hamilton KW, et al. Frequency of streamlining antimicrobial agents in patients with bacteremia. Infect Control Hosp Epidemiol. 2017;38:89–95.CrossRefPubMedGoogle Scholar
  19. 19.
    Reed EE, Stevenson KB, West JE, Bauer KA, Goff DA. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence. 2013;4:158–62.CrossRefPubMedGoogle Scholar
  20. 20.
    Graber CJ, Jones MM, Glassman PA, et al. Taking an antibiotic time-out: utilization and usability of a self-stewardship time-out program for renewal of vancomycin and piperacillin/tazobactam. Hosp Pharm. 2015;50:1011–24.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28:195–214.CrossRefPubMedGoogle Scholar
  22. 22.
    Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28:247–61.CrossRefGoogle Scholar
  23. 23.
    Sabui T, Tudehope DI, Tilse M. Clinical significance of quantitative blood cultures in newborn infants. J Paediatr Child Health. 1999;35:578–81.CrossRefPubMedGoogle Scholar
  24. 24.
    Schelonka RL, Chai MK, Yoder BA, Hensley D, Brockett RM, Ascher DP. Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996;129:275–8.CrossRefGoogle Scholar
  25. 25.
    Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.CrossRefGoogle Scholar
  26. 26.
    Connell TG, Rele M, Cowely D, Buttery JP, Curtis N. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children’s hospital. Pediatrics. 2007;119:891–6.CrossRefGoogle Scholar
  27. 27.
    Cantey JB, Sanchez PJ. Prolonged antibiotic therapy for “culture-negative” sepsis in preterm infants: it’s time to stop! J Pediatr. 2011;159:707–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the neonatal ICU. Pediatrics. 2017;140:e20170044.CrossRefPubMedGoogle Scholar
  29. 29.
    Ng PC, Ma TP, Lam HS. The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2015;100:F448–52.CrossRefPubMedGoogle Scholar
  30. 30.
    Perron S, Lotti F, Longini M, et al. C reactive protein in healthy term newborns during the first 48 hours of life. Arch Dis Child Fetal Neonatal Ed. 2018;103:F163–6.CrossRefGoogle Scholar
  31. 31.
    Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics. 2004;113:1173–80.CrossRefPubMedGoogle Scholar
  32. 32.
    Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–71.CrossRefPubMedGoogle Scholar
  33. 33.
    Warren S, Garcia M, Hankins C. Impact of neonatal early-onset sepsis calculator on antibiotic use within two tertiary health care centers. J Perinatol. 2017;37:394–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Chiu CH, Michelow IC, Cronin J, Ringer SA, Ferris TG, Puopolo KM. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J. 2011;30:273–8.CrossRefGoogle Scholar
  35. 35.
    Vamsi SR, Bhat RY, Lewis LE, Vandana KE. Time to positivity of blood cultures in neonates. Pediatr Infect Dis J. 2014;33:212–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Neonatal/Perinatal MedicineUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations